US Non Invasive Prenatal Testing Market (2024-2029)
The US Non Invasive Prenatal Testing Market was valued at $1505.8 Million in 2024 and projected to reach to $2861.5 Million by 2029, representing a compound annual growth rate of 13.7%. The US NIPT market is positioned for sustained growth through 2029, driven by demographic shifts, technological advancements, and evolving clinical guidelines that increasingly recommend non-invasive screening as first-line prenatal testing.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Non Invasive Prenatal Testing Market Trends and Insights
- The US market is driven by increasing maternal age, rising awareness of prenatal screening options, and growing adoption of advanced diagnostic technologies among healthcare providers and expectant parents.
- In the US, regulatory support from the FDA and expanding insurance coverage have accelerated market penetration across both urban and rural healthcare settings. The US NIPT market benefits from a well-established healthcare infrastructure, high disposable incomes, and strong demand for non-invasive diagnostic solutions that reduce pregnancy-related risks.
- Between 2024 and 2029, the US market is expected to grow at a compound annual growth rate (CAGR) of 13.7%, outpacing many global counterparts.
- This growth trajectory reflects the US healthcare system's emphasis on precision medicine, coupled with declining test costs and improved accessibility through major diagnostic laboratories and clinical networks..
Key Market Statistics
- CAGR (2024-2029) 13.7% CAGR
- Market Size, 2024 ~USD 1505.8 Million
- Forecast, 2029 ~USD 2861.5 Million
- Country US
US Non Invasive Prenatal Testing Market Overview
Market Valuation Growth :
The US NIPT market is valued at $1,505.8 million in 2024 and is projected to reach $2,861.5 million by 2029, representing a robust 13.7% CAGR, outpacing many other diagnostic segments in American healthcare.
Increasing Maternal Age Trends :
Rising average maternal age in the US is a primary driver of NIPT adoption, as older pregnancies carry higher risks of chromosomal abnormalities, making non-invasive screening an attractive option for expectant parents seeking safer diagnostic alternatives.
Healthcare Provider Adoption :
US healthcare providers are increasingly integrating NIPT into standard prenatal care protocols, driven by improved test accuracy, reduced turnaround times, and growing insurance coverage, making advanced screening accessible across diverse patient populations.
Regulatory Support & Reimbursement :
Strong FDA oversight and expanding insurance reimbursement policies in the US are facilitating market growth, with major payers recognizing NIPT's clinical value and cost-effectiveness compared to invasive diagnostic procedures like amniocentesis.
US Non Invasive Prenatal Testing Market Dynamics
- Expanding insurance coverage and growing consumer awareness of safer diagnostic options continue to broaden market penetration across urban and rural healthcare settings.
- The competitive landscape is intensifying as major diagnostic companies invest in next-generation sequencing technologies and expanded test panels, enhancing clinical utility and market accessibility.
- Regulatory clarity and evidence-based reimbursement policies will remain critical factors supporting market expansion and ensuring equitable access to NIPT across diverse US populations..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- The US NIPT market is valued at $1,505.8 million in 2024 and will nearly double to $2,861.5 million by 2029, driven by 13.7% CAGR growth.
- In the US, expanding insurance reimbursement policies and FDA regulatory clarity are accelerating adoption among obstetric practices and maternal-fetal medicine specialists.
- The US market benefits from advanced laboratory infrastructure, declining per-test costs, and increasing patient demand for safer, non-invasive prenatal screening alternatives.
- By 2029, the US NIPT market will represent a significant portion of prenatal diagnostics, supported by demographic trends including delayed childbearing and heightened genetic screening awareness.
Non Invasive Prenatal Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | CFDNA IN MATERNAL PLASMA (Method) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 14.5% from 2024 to 2029 |
| Largest Segment | TRISOMY (Application) |
| Market Size Base Year (Billions) | ~USD 7.16 (2024) |
| Revenue Forecast (Billions) | ~USD 14.1 (2029) |
| Segments Covered | Product & Service, Type, Method, Application, End User |
US Non Invasive Prenatal Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Products
- Services
By Type
- Assay Kits & Reagents
- Consumables
- Disposables
- Instruments
- Microarrays
- Ngs Systems
- Other Instruments
- Pcr Instruments
- Ultrasound Devices
By Method
- Biochemical Screening Tests
- Cfdna In Maternal Plasma
- Cfdna In Maternal Plasma Tests
- Ultrasound Detection
By Application
- Microdeletion Syndrome
- Other Applications
- Trisomy
By End User
- Diagnostic Laboratories
- Hospitals
Target Audience
- Diagnostic Laboratory Operators : US-based NIPT laboratories need market intelligence to benchmark performance, identify growth opportunities, optimize test pricing, and understand competitive positioning within the rapidly expanding American prenatal screening market.
- Medical Device & IVD Manufacturers : Companies developing NIPT platforms and sequencing technologies require US market data to guide product development priorities, forecast revenue potential, and align commercialization strategies with evolving American healthcare provider demands.
- Healthcare Providers & OB/GYN Practices : US obstetricians and maternal-fetal medicine specialists need market insights to understand NIPT adoption trends, reimbursement landscape, and clinical guideline evolution to optimize prenatal screening protocols and patient care delivery.
- Insurance & Payer Organizations : US health insurers and managed care organizations require detailed market analysis to evaluate NIPT coverage policies, assess cost-effectiveness, and make informed reimbursement decisions that balance clinical value with healthcare expenditure management.
- Investment & Private Equity Firms : Investors evaluating opportunities in the US prenatal diagnostics sector need comprehensive market data, growth projections, and competitive analysis to assess investment returns, identify acquisition targets, and evaluate portfolio company performance.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation data ($1,505.8M in 2024) and verified growth projections through 2029, enabling accurate financial forecasting and investment decision-making for stakeholders in the American prenatal diagnostics sector.
- Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, provider adoption patterns, and market consolidation trends to identify partnership opportunities, market entry strategies, and differentiation pathways for diagnostic companies and healthcare organizations.
- Reimbursement & Regulatory Insights : Access detailed analysis of US insurance coverage policies, FDA regulatory pathways, and payer reimbursement trends that directly impact market accessibility, pricing strategies, and revenue optimization for NIPT service providers and manufacturers.
- Customer Segmentation Data : Leverage US-specific demographic insights on maternal age trends, geographic adoption patterns, and patient preference data to refine marketing strategies, optimize distribution channels, and target high-growth patient segments effectively.
- Strategic Planning & Risk Mitigation : Develop informed US market strategies by understanding regional healthcare infrastructure, clinical guideline adoption, and emerging market barriers, enabling proactive risk management and resource allocation for sustainable business growth.
Frequently asked questions
What is the current size of the US Non Invasive Prenatal Testing market?
The US NIPT market was valued at $1,505.8 million in 2024 and is projected to grow to $2,861.5 million by 2029.
What is the expected growth rate for the US NIPT market through 2029?
The US NIPT market is expected to grow at a compound annual growth rate (CAGR) of 13.7% from 2024 to 2029.
What factors are driving growth in the US NIPT market?
Key drivers in the US include expanding insurance coverage, FDA regulatory support, declining test costs, increasing maternal age, and growing awareness of non-invasive screening options among healthcare providers and patients.
How does insurance coverage impact NIPT adoption in the US?
In the US, expanding insurance reimbursement for NIPT has significantly increased accessibility and adoption rates, making the test more affordable for expectant parents across diverse socioeconomic backgrounds.
Which demographic trends are supporting the US NIPT market expansion?
The US NIPT market is supported by delayed childbearing, increased maternal age, heightened genetic screening awareness, and a growing preference for non-invasive diagnostic solutions among informed patients.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current non-invasive prenatal testing (NIPT) market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the non-invasive prenatal testing (NIPT) market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer non-invasive prenatal testing (NIPT) product and service. Primary sources from the demand side include industry experts such as doctors, hospital directors and managers, and other medical professionals.
Primary research was conducted to identify segmentation types; industry trends; technology trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, and key player strategies.
Note 1: Others include sales, marketing, and product managers.
Note 2: Their total revenues define the tiers of companies as of 2023, tier 1 = >USD 500 million, tier 2 = USD 200 million to USD 500 million, and tier 3 = <USD 200 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the non-invasive prenatal testing (NIPT) market was arrived at after data triangulation from four different approaches, as mentioned below.
Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the medical device cleaning businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.
Country level Analysis: The size of the non-invasive prenatal testing (NIPT) market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of non-invasive prenatal testing (NIPT) products in the overall non-invasive prenatal testing (NIPT) market was obtained from secondary data and validated by primary participants to arrive at the total non-invasive prenatal testing (NIPT) market. Primary participants further validated the numbers.
Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall non-invasive prenatal testing (NIPT) market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
After complete market engineering with calculations for market statistics, market size estimations, market forecasting, market breakdown, and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and further quantitative analysis was also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Global Non-invasive prenatal testing (NIPT) market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Non-invasive prenatal testing (NIPT) market Size: Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.
Approach to derive the market size and estimate market growth
The market rankings for leading players were ascertained after a detailed assessment of their revenues from the non-invasive prenatal testing (NIPT) business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.
Market Definition
Non-invasive prenatal testing (NIPT) is a method used to screen chromosomal abnormalities in a developing fetus by analyzing small fragments of fetal Cell-Free DNA circulating in a pregnant woman's blood. Non-invasive prenatal tests enable the detection of chromosomal abnormalities, such as trisomy 21 (Down Syndrome), trisomy 18 (Edwards' Syndrome), trisomy 13 (Patau Syndrome), microdeletion syndrome, and other genetic conditions. This market encompasses products such as assay kits and reagents, next generation sequencing systems, and diagnostic services offered by laboratories.
Key Stakeholders
- Non-invasive prenatal testing product manufacturing companies
- Hospitals and private clinics
- Diagnostic laboratories
- Medical research institutes
- Market research and consulting firms
- Suppliers and distributors of NIPT instruments
- Venture capitalists and investors
- Regulatory agencies and government bodies
Objectives of the Study
- To define, describe, and forecast the global non-invasive prenatal testing (NIPT) market on the basis of product and service, method, application, end user, and region
- To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
- To strategically analyze the regulatory scenario, pricing trends, value chain, supply chain, ecosystem analysis, key stakeholders and buying criteria, technology scenario, patent scenario, and key conferences and events in the market
- To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall udder health market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies.
- To strategically analyze the udder health market in five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as acquisitions, partnerships, and expansions in the udder health market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific non-invasive prenatal testing (NIPT) market into China, Japan, India, South Korea, and other countries.
Get the Full Non Invasive Prenatal Testing Market Report
Full forecast, segment splits, and company analysis for all Non Invasive Prenatal Testing Market.
- France Non Invasive Prenatal Testing Market
- Italy Non Invasive Prenatal Testing Market
- Spain Non Invasive Prenatal Testing Market
- Japan Non Invasive Prenatal Testing Market
- China Non Invasive Prenatal Testing Market
- India Non Invasive Prenatal Testing Market
- Australia Non Invasive Prenatal Testing Market
- South Korea Non Invasive Prenatal Testing Market
- Brazil Non Invasive Prenatal Testing Market
- Mexico Non Invasive Prenatal Testing Market
- Rest Of Europe Non Invasive Prenatal Testing Market
- Rest Of Asia Pacific Non Invasive Prenatal Testing Market
- Rest Of Latin America Non Invasive Prenatal Testing Market
- Canada Non Invasive Prenatal Testing Market
- UK Non Invasive Prenatal Testing Market
- Germany Non Invasive Prenatal Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
